Overview
Ravi Anandakrishnan is a Hematologist and an Oncologist in Baltimore, Maryland. Dr. Anandakrishnan is rated as an Experienced provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Pulmonary Embolism, Lung Cancer, Pleuropulmonary Blastoma, and Thrombocytopenia. Dr. Anandakrishnan is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3304 Guilford Ave, Baltimore, MD 21218
9000 Franklin Square Dr, Baltimore, MD 21237
5601 Lloch Raven Blvd, Baltimore, MD 21239
1406 Crain S Hwy 106, Glen Burnie, MD 21061
3001 S Hanover St, Baltimore, MD 21225
Skip Viragh Outpatient Cancer Center
Dr. Mark Yarchoan is a physician–scientist based in Baltimore who specializes in the treatment and study of gastrointestinal cancers, with a particular focus on liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). He received his undergraduate degree from Amherst College and his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine, where he joined the faculty in 2018. Dr. Yarchoan leads a research laboratory dedicated to developing novel immunotherapies for liver cancers. His translational research program integrates analyses of clinical trial biospecimens with preclinical modeling to identify and overcome barriers to effective antitumor immunity. A major focus of his work is the development of therapeutic cancer vaccines for hepatobiliary malignancies. He serves as Principal Investigator on multiple clinical trials for hepatobiliary cancers, contributes to international guideline committees for liver cancer, and is a member of the Johns Hopkins Graduate Training Programs in Cellular and Molecular Medicine and Immunology. Dr. Yarchoan’s contributions have been recognized with numerous honors, including the ASCO Young Investigator Award, the Conquer Cancer Foundation Career Development Award, the Mark R. Clements Award from the Cholangiocarcinoma Foundation, and the Blue Faery Award for Excellence in Liver Cancer Research. Dr. Yarchoan is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Pancreatic Cancer, and Hepatectomy.
Elizabeth Jaffee is an Oncologist in Baltimore, Maryland. Dr. Jaffee is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. Her top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Fibrolamellar Carcinoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.
Medical Oncology Hematology Consultants
Evan Lapinsky is a Hematologist and an Internal Medicine provider in Middletown, Delaware. Dr. Lapinsky is rated as an Advanced provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Anemia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerDr. Anandakrishnan isAdvanced. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Anandakrishnan isAdvanced. Learn about Pleuropulmonary Blastoma.
- Pulmonary EmbolismDr. Anandakrishnan isAdvanced. Learn about Pulmonary Embolism.
- ThrombocytopeniaDr. Anandakrishnan isAdvanced. Learn about Thrombocytopenia.
- Experienced
- Adult Immune ThrombocytopeniaDr. Anandakrishnan isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult T-Cell LeukemiaDr. Anandakrishnan isExperienced. Learn about Adult T-Cell Leukemia.
- ALK-Positive Non-Small Cell Lung CancerDr. Anandakrishnan isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Anandakrishnan isExperienced. Learn about Anemia.
- AngiosarcomaDr. Anandakrishnan isExperienced. Learn about Angiosarcoma.
- Arterial EmbolismDr. Anandakrishnan isExperienced. Learn about Arterial Embolism.


